Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
PathAI
PathAIPathAI Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
What is becoming different about PathAI over time?
Movement over time
Earlier activity concentrated on workflow friction, adoption state, accuracy quality.
Earlier period
Movement over time
More recent activity concentrates on adoption state, workflow friction, accuracy quality.
Recent period
Public evidence
FDA 510(k) Clearance Summary for AISight Dx
SignalHunt:validation:PathAI
Public evidence
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide
SignalHunt:deployment:PathAI
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 158 public external signal(s) across 10 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands PathAI through regulatory records, a published study, deployment evidence, company records and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand PathAI. As evidence and experience accumulate, what remains unclear will be stated here.
Across organisations
Where PathAI's reality is forming
Public activity and lived reality are separate truths. Public presence never implies local deployment or success.
- Open MedStar Health × PathAI
MedStar Health
Public activity reported (24 records)
No lived-reality response yet
Nobody here has described actually using it yet.
- Open Northwestern Medicine × PathAI
Northwestern Medicine
Public activity reported (4 records)
No lived-reality response yet
Nobody here has described actually using it yet.
- Open Mayo Clinic × PathAI
Mayo Clinic
Public activity reported (1 record)
No lived-reality response yet
Nobody here has described actually using it yet.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
PathAI provides the AISight Dx platform for digital pathology. The software enables clinicians to manage images, annotate slides, and collaborate on diagnostic cases.According to PathAI
What PathAI states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The platform facilitates live, synchronized slide review and case collaboration among pathologists.
According to PathAI
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
PathAI and Moffitt Cancer Center announce strategic collaboration to deploy the AISight Dx digital pathology platform
Reported publicly
How widely is this actually used?
Reported deployment
PathAI and A.C.Camargo Cancer Center Announce Cooperation to Expand Digital Pathology with AI in Brazil via SUS
Reported publicly
How widely is this actually used?
Reported outcome
PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExplore™ for Standardized Histopathology Endpoints
Reported publicly
Are you seeing this result?
Recent change
FDA 510(k) Clearance Summary for AISight Dx
Reported publicly
A matter of record — context, not something practice can confirm.
Recent change
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide
Reported publicly
A matter of record — context, not something practice can confirm.
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
• Overview: PathAI is a leading provider of AI-driven digital pathology solutions designed to improve the accuracy and efficiency of histological assessments. The platform leverages advanced machine learning algorithms to analyze and interpret pathology images, providing valuable insights to pathologists,…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings
Key strength
Regulatory: FDA Breakthrough Device Designation
How the reality here has changed
Earlier activity concentrated on workflow friction, adoption state, accuracy quality. More recent activity concentrates on adoption state, workflow friction, accuracy quality.
Earlier
- workflow friction
- adoption state
- accuracy quality
More recently
- adoption state
- workflow friction
- accuracy quality
Connected intelligence
Category intelligence
Related technologies
Organisation intelligence